Literature DB >> 29719258

PPM1K Regulates Hematopoiesis and Leukemogenesis through CDC20-Mediated Ubiquitination of MEIS1 and p21.

Xiaoye Liu1, Feifei Zhang2, Yaping Zhang3, Xie Li4, Chiqi Chen3, Meiyi Zhou3, Zhuo Yu3, Yunxia Liu3, Yuzheng Zhao4, Xiaoxin Hao3, Yabin Tang5, Liang Zhu5, Ligen Liu3, Li Xie3, Hao Gu1, Hongfang Shao6, Fangzhen Xia3, Chunrong Yin3, Minfang Tao6, Jingjing Xie7, Cheng Cheng Zhang8, Yi Yang9, Haipeng Sun10, Guo-Qiang Chen11, Junke Zheng12.   

Abstract

In addition to acting as building blocks for biosynthesis, amino acids might serve as signaling regulators in various physiological and pathological processes. However, it remains unknown whether amino acid levels affect the activities of hematopoietic stem cells (HSCs). By using a genetically encoded fluorescent sensor of the intracellular levels of branched-chain amino acids (BCAAs), we could monitor the dynamics of BCAA metabolism in HSCs. A mitochondrial-targeted 2C-type Ser/Thr protein phosphatase (PPM1K) promotes the catabolism of BCAAs to maintain MEIS1 and p21 levels by decreasing the ubiquitination-mediated degradation controlled by the E3 ubiquitin ligase CDC20. PPM1K deficiency led to a notable decrease in MEIS1/p21 signaling to reduce the glycolysis and quiescence of HSCs, followed by a severe impairment in repopulation activities. Moreover, the deletion of Ppm1k dramatically extended survival in a murine leukemia model. These findings will enhance the current understanding of nutrient signaling in metabolism and function of stem cells.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDC20; MEIS1/p21; PPM1K; branched-chain amino acids; hematopoietic stem cells; leukemia-initiating cells; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29719258     DOI: 10.1016/j.celrep.2018.03.140

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  12 in total

1.  Transcription factor Meis1 act as a new regulator of ischemic arrhythmias in mice.

Authors:  Yining Liu; Jiamin Li; Ning Xu; Hang Yu; Liling Gong; Qingsui Li; Zhenyu Yang; Sijia Li; Jiming Yang; Di Huang; Yadong Xue; Genlong Xue; Jiali Liu; Haixin Chen; Ruijie Zhang; Anqi Li; Yiming Zhao; PengYu Li; Ming Li; Mingbin Liu; Ning Wang; Benzhi Cai
Journal:  J Adv Res       Date:  2021-11-15       Impact factor: 12.822

2.  The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma.

Authors:  Juanni Li; Xiaofang Zhang; Lei Yao; Kuan Hu
Journal:  Aging (Albany NY)       Date:  2022-05-27       Impact factor: 5.955

Review 3.  Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche.

Authors:  Rebecca S Maynard; Charlotte Hellmich; Kristian M Bowles; Stuart A Rushworth
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

Review 4.  Genetically encoded tools for measuring and manipulating metabolism.

Authors:  Mangyu Choe; Denis V Titov
Journal:  Nat Chem Biol       Date:  2022-04-28       Impact factor: 16.174

Review 5.  Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

Authors:  Ismael Y Karkache; Jeyaram R Damodaran; David H H Molstad; Elizabeth W Bradley
Journal:  Gene       Date:  2020-12-16       Impact factor: 3.688

6.  CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma.

Authors:  Yue Huang; Yingqin Zhu; Jieying Yang; Qiuzhong Pan; Jingjing Zhao; Mengjia Song; Chaopin Yang; Yulong Han; Yan Tang; Qijing Wang; Jia He; Yongqiang Li; Junyi He; Hao Chen; Desheng Weng; Tong Xiang; Jian Chuan Xia
Journal:  Cell Death Dis       Date:  2022-03-19       Impact factor: 8.469

Review 7.  CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.

Authors:  Samantha Bruno; Andrea Ghelli Luserna di Rorà; Roberta Napolitano; Simona Soverini; Giovanni Martinelli; Giorgia Simonetti
Journal:  J Exp Clin Cancer Res       Date:  2022-04-30

Review 8.  Multifaceted role of branched-chain amino acid metabolism in cancer.

Authors:  Hui Peng; Yingfei Wang; Weibo Luo
Journal:  Oncogene       Date:  2020-09-25       Impact factor: 9.867

Review 9.  MEIS1 and its potential as a cancer therapeutic target (Review).

Authors:  Maozhong Yao; Yong Gu; Zhaoxin Yang; Keyan Zhong; Zhanjuan Chen
Journal:  Int J Mol Med       Date:  2021-07-28       Impact factor: 4.101

10.  LncRNA-ZXF1 stabilizes P21 expression in endometrioid endometrial carcinoma by inhibiting ubiquitination-mediated degradation and regulating the miR-378a-3p/PCDHA3 axis.

Authors:  Deshui Kong; Yixin Hou; Wenzhi Li; Xiaohong Ma; Jie Jiang
Journal:  Mol Oncol       Date:  2021-03-22       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.